Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma

An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma

04 Nov 2022 5:56 PM | Anonymous

Cools-Lartigue, Jonathan MD, PhD*; Markar, Sheraz MD, PhD†,‡; Mueller, Carmen MD, MSc*; Hofstetter, Wayne MD§; Nilsson, Magnus MD, PhD∥,¶; Ilonen, Ilkka MD, PhD#; Soderstrom, Henna MD, PhD*,#; Rasanen, Jari MD, PhD#; Gisbertz, Suzanne MD, PhD**,††; Hanna, George B. MD, PhD†; Elliott, Jessie MD, PhD‡‡; Reynolds, John MD, PhD‡‡; Kisiel, Aaron MD, PhD§§; Griffiths, Ewen MD, PhD§§,∥∥; Van Berge Henegouwen, Mark MD, PhD**,††; Ferri, Lorenzo MD, PhD*

Read Abstract: An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software